Abstract

Abnormally elevated expression of the imprinted PHLDA2 gene has been reported in the placenta of human babies that are growth restricted in utero in several studies. We previously modelled this gene alteration in mice and found that just 2-fold increased expression of Phlda2 resulted in placental endocrine insufficiency. In addition, elevated Phlda2 was found to drive fetal growth restriction (FGR) of transgenic offspring and impaired maternal care by their wildtype mothers. Being born small and being exposed to suboptimal maternal care have both been associated with the increased risk of mental health disorders in human populations. In the current study we probed behavioural consequences of elevated Phlda2 for the offspring. We discovered increased anxiety-like behaviours, deficits in cognition and atypical social behaviours, with the greatest impact on male offspring. Subsequent analysis revealed alterations in the transcriptome of the adult offspring hippocampus, hypothalamus and amygdala, regions consistent with these behavioural observations. The inclusion of a group of fully wildtype controls raised in a normal maternal environment allowed us to attribute behavioural and molecular alterations to the adverse maternal environment induced by placental endocrine insufficiency rather than the specific gene change of elevated Phlda2. Our work demonstrates that a highly common alteration reported in human FGR is associated with negative behavioural outcomes later in life. Importantly, we also establish the experimental paradigm that placental endocrine insufficiency can program atypical behaviour in offspring highlighting the under-appreciated role of placental endocrine insufficiency in driving disorders of later life behaviour.

Highlights

  • Fetal growth restriction (FGR) is a condition where the baby’s growth slows in utero resulting in birth weight significantly lower than normal [1]

  • Behavioural analysis was conducted on male and female transgenic (Phlda2+/+BACx1(129); Tg) and non-transgenic littermates (Phlda2+/+; NTg) studied concurrently with fully wildtype (Phlda2+/+; WT) animals to control for the impact of the adverse maternal environment

  • Animals were tested in three separate cohorts of either N = 20 or 12, depending on the testing regime, and individual outcome measures were assigned to categories broadly encompassing the behavioural traits they probe (Supplementary Material, Table S1)

Read more

Summary

Introduction

Fetal growth restriction (FGR) is a condition where the baby’s growth slows in utero resulting in birth weight significantly lower than normal [1]. This genetic combination normalized Phlda expression levels and restored placental weight and the junctional zone to near normal proportions in the model [25] In this same study, mice carrying three copies of a bacterial artificial chromosome (BAC) transgene spanning Phlda were reported to have smaller placenta and to be >10% lighter at embryonic day 16.5 (E16.5) [25]. Further studies on a single copy BAC transgenic line more precisely identified the function of Phlda as a negative regulator of just the spongiotrophoblast lineage with 2-fold Phlda resulting in a 40% loss of this lineage in the mature mouse placenta and loss-offunction has the opposite effect, with an expanded spongiotrophoblast and no significant impact on the size of the glycogen cell lineage [26,27]. Phlda transgenic offspring expressing 2-fold Phlda are growth restricted in utero, and both they and their non-transgenic littermates experience the same adverse maternal environment as a result of placental endocrine insufficiency

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call